[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Reuters Legal [@ReutersLegal](/creator/twitter/ReutersLegal) on x 100K followers Created: 2025-07-23 22:15:12 UTC Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in XX countries next year, the Indian drugmaker's CEO, Erez Israeli, said on Wednesday.  **Related Topics** [countries](/topic/countries) [wegovy](/topic/wegovy) [novo](/topic/novo) [$drreddyns](/topic/$drreddyns) [dr reddys](/topic/dr-reddys) [Post Link](https://x.com/ReutersLegal/status/1948144895929024833)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Reuters Legal @ReutersLegal on x 100K followers
Created: 2025-07-23 22:15:12 UTC
Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in XX countries next year, the Indian drugmaker's CEO, Erez Israeli, said on Wednesday.
Related Topics countries wegovy novo $drreddyns dr reddys
/post/tweet::1948144895929024833